Sabby Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-328
Closed -$75.7M 162
2017
Q4
$75.7M Buy
328
+25
+8% +$50.8K 6.89% 3
2017
Q3
$54M Buy
303
+111
+58% +$155K 3.53% 8
2017
Q2
$26.2M Buy
192
+45
+31% +$54.3K 1.71% 13
2017
Q1
$17.3M Buy
147
+101
+220% +$103K 0.93% 20
2016
Q4
$3.67M Sell
46
-61
-57% -$48.4K 0.21% 70
2016
Q3
$9.35M Buy
+107
New +$77.5K 0.35% 48
2016
Q1
Sell
-66
Closed -$5.53M 306
2015
Q4
$5.53M Sell
66
-3
-4% -$3K 0.3% 56
2015
Q3
$7.61M Sell
69
-41
-37% -$74.8K 0.31% 55
2015
Q2
$24.1M Sell
110
-121
-52% -$246K 0.88% 21
2015
Q1
$36.2M Buy
231
+125
+118% +$165K 1.51% 13
2014
Q4
$12.6K Buy
106
+29
+38% +$19.4K 0.4% 34
2014
Q3
$3.56K Buy
77
+24
+45% +$11.1K 0.14% 72
2014
Q2
$2.66M Buy
+53
New +$17K 0.11% 86

Other funds holding BLUE

Sabby Management's BLUE Position: Q1 2016 in Review

Sabby Management sold out of bluebird bio (BLUE) in Q1 2016, closing a stake of 3,509 shares — an estimated $2.92M sold.

Sabby Management first reported a position in BLUE in Q4 2013 and held it in 4 quarters. The position peaked at $2.92M in Q4 2015. 187 funds tracked by Wall St. Rank hold BLUE as of Q1 2016.

  • Sabby Management reported no remaining bluebird bio position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 3,509 bluebird bio shares in Q1 2016, an estimated $2.92M.
  • Sabby Management first reported a position in bluebird bio in Q4 2013 and held it in 4 quarters.
  • Sabby Management's bluebird bio position peaked at $2.92M in Q4 2015.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.